Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “January 2011”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5

Quality of Life After Palliative Radiation Therapy for Patients With Painful Bone Metastases: Results of an International Study Validating the EORTC QLQ-BM22

Purpose: Radiation therapy (RT) is an effective method of palliating painful bone metastases and can improve function and reduce analgesic requirements. In advanced cancer patients, quality of life (QOL) is the primary outcome of interest over traditional endpoints such as survival. The purpose of our study was to compare bone metastasis-specific QOL scores among patients who responded differently to palliative RT. Methods and Materials: Patients receiving RT for bone metastases across 6 countries were prospectively enrolled from March 2010-January 2011 in a trial validating the QLQ-BM22 and completed the QLQ-BM22 and the core measure (QLQ-C30) at baseline and after 1 month. Pain scores and analgesic intake were recorded, and response to RT was determined according to the latest published guidelines. The Kruskal-Wallis nonparametric and Wilcoxon rank sum tests compared changes in QOL among response groups. A Bonferroni-adjusted P<.003 indicated statistical significance. Results: Of 79 patients who received palliative RT, 59 were assessable. Partial response, pain progression, and indeterminate response were observed in 22, 8, and 29 patients, respectively; there were no patients with a complete response. Patients across all groups had similar baseline QOL scores apart from physical functioning (patients who progressed had better initial functioning). One month after RT, patients who responded had significant improvements in 3 of 4 QLQ-BM22 domains (painful site, P<.0001; painful characteristic, P<.0001; and functional interference, P<.0001) and 3 QLQ-C30 domains (physical functioning, P=.0006; role functioning, P=.0026; and pain, P<.0001). Patients with progression in pain had significantly worse functional interference (P=.0007) and pain (P=.0019). Conclusions: Patients who report pain relief after palliative RT also have better QOL with respect to bone metastasis-specific issues. The QLQ-BM22 and QLQ-C30 are able to discriminate among patients with varying responses and are recommended for use in future bone metastasis clinical trials.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Outcome of Patients Treated With a Single-Fraction Dose of Palliative Radiation for Cutaneous T-Cell Lymphoma

Purpose: Cutaneous T-cell lymphoma (CTCL) is a radiosensitive tumor. Presently, treatment with radiation is given in multiple fractions. The current literature lacks data that support single-fraction treatment for CTCL. This retrospective review assesses the clinical response in patients treated with a single fraction of radiation. Methods and Materials: This study reviewed the records of 58 patients with CTCL, primarily mycosis fungoides, treated with a single fraction of palliative radiation therapy (RT) between October 1991 and January 2011. Patient and tumor characteristics were reviewed. Response rates were compared using Fisher's exact test and multiple logistic regressions. Survival rates were determined using the Kaplan-Meier method. Cost-effectiveness analysis was performed to assess the cost of a single vs a multifractionated treatment regimen. Results: Two hundred seventy individual lesions were treated, with the majority (97%) treated with ≥700 cGy; mean follow-up was 41.3 months (range, 3-180 months). Response rate by lesion was assessed, with a complete response (CR) in 255 (94.4%) lesions, a partial response in 10 (3.7%) lesions, a partial response converted to a CR after a second treatment in 4 (1.5%) lesions, and no response in 1 (0.4%) lesion. The CR in lower extremity lesions was lower than in other sites (P=.0016). Lesions treated with photons had lower CR than those treated with electrons (P=.017). Patients with lesions exhibiting large cell transformation and tumor morphology had lower CR (P=.04 and P=.035, respectively). Immunophenotype did not impact response rate (P=.23). Overall survival was significantly lower for patients with Sézary syndrome (P=.0003) and erythroderma (P<.0001). The cost of multifractionated radiation was >200% higher than that for single-fraction radiation. Conclusions: A single fraction of 700 cGy-800 cGy provides excellent palliation for CTCL lesions and is cost effective and convenient for the patient.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Prognostic Importance of Gleason 7 Disease Among Patients Treated With External Beam Radiation Therapy for Prostate Cancer: Results of a Detailed Biopsy Core Analysis

Purpose: To analyze the effect of primary Gleason (pG) grade among a large cohort of Gleason 7 prostate cancer patients treated with external beam radiation therapy (EBRT). Methods and Materials: From May 1989 to January 2011, 1190 Gleason 7 patients with localized prostate cancer were treated with EBRT at a single institution. Of these patients, 613 had a Gleason 7 with a minimum of a sextant biopsy with nonfragmented cores and full biopsy core details available, including number of cores of cancer involved, percentage individual core involvement, location of disease, bilaterality, and presence of perineural invasion. Median follow-up was 6 years (range, 1-16 years). The prognostic implication for the following outcomes was analyzed: biochemical recurrence-free survival (bRFS), distant metastasis-free survival (DMFS), and prostate cancer-specific mortality (PCSM). Results: The 8-year bRFS rate for pG3 versus pG4 was 77.6% versus 61.3% (P<.0001), DMFS was 96.8% versus 84.3% (P<.0001), and PCSM was 3.7% versus 8.1% (P=.002). On multivariate analysis, pG4 predicted for significantly worse outcome in all parameters. Location of disease (apex, base, mid-gland), perineural involvement, maximum individual core involvement, and the number of Gleason 3+3, 3+4, or 4+3 cores did not predict for distant metastases. Conclusions: Primary Gleason grade 4 independently predicts for worse bRFS, DMFS, and PCSM among Gleason 7 patients. Using complete core information can allow clinicians to utilize pG grade as a prognostic factor, despite not having the full pathologic details from a prostatectomy specimen. Future staging and risk grouping should investigate the incorporation of primary Gleason grade when complete biopsy core information is used.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Toxicity After Central versus Peripheral Lung Stereotactic Body Radiation Therapy: A Propensity Score Matched-Pair Analysis

Purpose: To compare toxicity after stereotactic body radiation therapy (SBRT) for “central” tumors—within 2 cm of the proximal bronchial tree or with planning tumor volume (PTV) touching mediastinum—versus noncentral (“peripheral”) lung tumors. Methods and Materials: From November 2005 to January 2011, 229 tumors (110 central, 119 peripheral; T1-3N0M0 non–small-cell lung cancer and limited lung metastases) in 196 consecutive patients followed prospectively at a single institution received moderate-dose SBRT (48-60 Gy in 4-5 fractions [biologic effective dose=100-132 Gy, α/β=10]) using 4-dimensional planning, online image-guided radiation therapy, and institutional dose constraints. Clinical adverse events (AEs) were graded prospectively at clinical and radiographic follow-up using Common Terminology Criteria for Adverse Events version 3.0. Pulmonary function test (PFT) decline was graded as 2 (25%-49.9% decline), 3 (50.0%-74.9% decline), or 4 (≥75.0% decline). Central/peripheral location was assessed retrospectively on planning CT scans. Groups were compared after propensity score matching. Characteristics were compared with χ{sup 2} and 2-tailed t tests, adverse events with χ{sup 2} test-for-trend, and cumulative incidence using competing risks analysis (Gray's test). Results: With 79 central and 79 peripheral tumors matched, no differences in AEs were observed after 17 months median follow-up. Two-year cumulative incidences of grade ≥2 pain, musculoskeletal, pulmonary, and skin AEs were 14%, 5%, 6%, and 10% (central) versus 19%, 10%, 10%, and 3% (peripheral), respectively (P=.31, .38, .70, and .09). Grade ≥2 cardiovascular, gastrointestinal, and central nervous system AEs were rare (<1%). Two-year incidences of grade ≥2 clinical AEs (28% vs 25%, P=.79), grade ≥2 PFT decline (36% vs 34%, P=.94), grade ≥3 clinical AEs (3% vs 7%, P=.48), and grade ≥3 PFT decline (0 vs 10%, P=.11) were similar for central versus peripheral tumors, respectively. Pooled 2-year incidences of grades 4 and 5 AEs were <1% and 0%, respectively, in both the prematched and matched groups. Conclusion: Moderate-dose SBRT with these techniques yields a similarly safe toxicity profile for both central and peripheral lung tumors.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer

Purpose: Resection of exocrine pancreatic cancer is necessary for cure, but locoregional and distant relapse is common. We evaluated our institutional experience to better understand risk factors for locoregional failure (LRF) and its impact on overall survival (OS). Methods and Materials: We reviewed 1051 consecutive patients with nonmetastatic exocrine pancreatic cancer who underwent resection at our institution between March 1987 and January 2011. Among them, 458 had adequate follow-up and evaluation for study inclusion. All patients received adjuvant chemotherapy (n=80 [17.5%]) or chemoradiation therapy (n=378 [82.5%]). Chemotherapy and chemoradiation therapy most frequently consisted of 6 cycles of gemcitabine and 50.4 Gy in 28 fractions with concurrent 5-fluorouracil, respectively. Locoregional control (LRC) and OS were estimated with the Kaplan-Meier method. Univariate and multivariate analyses were performed with Cox proportional hazards regression models incorporating propensity score. Results: Median patient age was 64.5 years (range: 29-88 years). Median follow-up for living patients was 84 months (range: 6-300 months). Extent of resection was R0 (83.8%) or R1 (16.2%). Overall crude incidence of LRF was 17% (n=79). The 5-year LRC for patients with and without radiation therapy was 80% and 68%, respectively (P=.003; hazard ratio [HR]: 0.45; 95% confidence interval [CI]: 0.28-0.76). Multivariate analysis, incorporating propensity score, indicated radiation therapy (P<.0001; HR: 0.23; 95% CI: 0.12-0.42) and positive lymph node ratio of ≥0.2 (P=.02; HR: 1.78; 95% CI: 1.10-2.9) were associated with LRC. In addition, LRF was associated with worse OS (P<.0001; HR: 5.0; 95% CI: 3.9-6.3). Conclusions: In our analysis of 458 patients with resected pancreatic cancer, positive lymph node ratio of ≥0.2 and no adjuvant chemoradiation therapy were associated with increased LRF risk. LRF was associated with poor OS. Radiation therapy should be considered as adjuvant locoregional treatment following pancreatic cancer resection.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Identifying Predictive Factors for Incident Reports in Patients Receiving Radiation Therapy

Purpose: To describe radiation therapy cases during which voluntary incident reporting occurred; and identify patient- or treatment-specific factors that place patients at higher risk for incidents. Methods and Materials: We used our institution's incident learning system to build a database of patients with incident reports filed between January 2011 and December 2013. Patient- and treatment-specific data were reviewed for all patients with reported incidents, which were classified by step in the process and root cause. A control group of patients without events was generated for comparison. Summary statistics, likelihood ratios, and mixed-effect logistic regression models were used for group comparisons. Results: The incident and control groups comprised 794 and 499 patients, respectively. Common root causes included documentation errors (26.5%), communication (22.5%), technical treatment planning (37.5%), and technical treatment delivery (13.5%). Incidents were more frequently reported in minors (age <18 years) than in adult patients (37.7% vs 0.4%, P<.001). Patients with head and neck (16% vs 8%, P<.001) and breast (20% vs 15%, P=.03) primaries more frequently had incidents, whereas brain (18% vs 24%, P=.008) primaries were less frequent. Larger tumors (17% vs 10% had T4 lesions, P=.02), and cases on protocol (9% vs 5%, P=.005) or with intensity modulated radiation therapy/image guided intensity modulated radiation therapy (52% vs 43%, P=.001) were more likely to have incidents. Conclusions: We found several treatment- and patient-specific variables associated with incidents. These factors should be considered by treatment teams at the time of peer review to identify patients at higher risk. Larger datasets are required to recommend changes in care process standards, to minimize safety risks.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer

Purpose: To report early outcome analysis of a prospective institutional phase 2 trial of weekly hypofractionated breast irradiation (WHBI) for patients undergoing breast-conserving surgery (BCS). Methods and Materials: Patients who underwent BCS for American Joint Committee on Cancer stage 0, I, or II breast cancer with negative surgical margins received whole-breast radiation therapy to 30 or 28.5 Gy in 5 weekly fractions with or without an additional boost. The eligibility criteria were the same as for NSABP (National Surgical Adjuvant Breast and Bowel Project) B39/RTOG (Radiation Therapy Oncology Group) 0413, and there were no restrictions on age, breast size, tumor grade, receptor status, or the use of cytotoxic chemotherapy for otherwise eligible patients. The primary endpoint was ipsilateral breast tumor recurrence. Patients were also evaluated for acute toxicity (Common Terminology Criteria for Adverse Events version 3.0), cosmesis (Harvard Scale), development of distant metastatic disease, and overall survival. Results: Between January 2011 and October 2015, 158 eligible patients underwent WHBI immediately following BCS. The median age was 60 years (range, 30-84 years), and the median follow-up period was 3 years. Ipsilateral breast tumor recurrence developed in a total of 2 patients (1.3%), 1 in conjunction with widespread metastatic disease. Distant metastatic disease developed in 4 patients (2.5%), and the 3-year disease-free survival and overall survival rates were 97.5% and 96.2%, respectively. The most common grade 1 or 2 acute toxicities were breast pain, radiation dermatitis, and fatigue. There were 2 grade 3 events (1.3%): pain requiring narcotic analgesics (1) and posttreatment infection requiring hospitalization (1). The rate of excellent or good cosmesis versus fair or poor cosmesis was 82.3% versus 17.7%. The rate of significant cosmetic change from baseline to last follow-up (dropping from excellent or good to fair or poor) was 11.6%. Conclusions: Early outcomes after WHBI are favorable and parallel those seen with daily hypofractionated whole-breast irradiation. With broader entry criteria than all previous reports of WHBI, this study will facilitate comparison to the results of NSABP B39/RTOG 0413. With continued follow-up, future reports will assess cosmetic stability and disease-specific outcomes.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

The European Spallation Source

In 2003 the joint European effort to design a European Spallation Source (ESS) resulted in a set of reports, and in May 2009 Lund was agreed to be the ESS site. The ESS Scandinavia office has since then worked on setting all the necessary legal and organizational matters in place so that the Design Update and construction can be started in January 2011, in collaboration with European partners. The Design Update phase is expected to end in 2012, to be followed by a construction phase, with first neutrons expected in 2018-2019.

43 PARTICLE ACCELERATORS↗

Radio to gamma-ray variability study of blazar S5 0716+714

In this paper, we present the results of a series of radio, optical, X-ray, and γ-ray observations of the BL Lac object S50716+714 carried out between April 2007 and January 2011. The multifrequency observations were obtained using several ground- and space-based facilities. The intense optical monitoring of the source reveals faster repetitive variations superimposed on a long-term variability trend on a time scale of ~350 days. Episodes of fast variability recur on time scales of ~60-70 days. The intense and simultaneous activity at optical and γ-ray frequencies favors the synchrotron self-Compton mechanism for the production of the high-energy emission. Two major low-peaking radio flares were observed during this high optical/γ-ray activity period. The radio flares are characterized by a rising and a decaying stage and agrees with the formation of a shock and its evolution. We found that the evolution of the radio flares requires a geometrical variation in addition to intrinsic variations of the source. Different estimates yield robust and self-consistent lower limits of δ ≥ 20 and equipartition magnetic field B eq ≥ 0.36 G. Causality arguments constrain the size of emission region θ ≤ 0.004 mas. We found a significant correlation between flux variations at radio frequencies with those at optical and γ-rays. Theoptical/GeV flux variations lead the radio variability by ~65 days. The longer time delays between low-peaking radio outbursts and optical flares imply that optical flares are the precursors of radio ones. An orphan X-ray flare challenges the simple, one-zone emission models, rendering them too simple. Finally, here we also describe the spectral energy distribution modeling of the source from simultaneous data taken through different activity periods.

79 ASTRONOMY AND ASTROPHYSICS↗

Status of PLS-II Upgrade Program

The Pohang Light Source (PLS) at the Pohang Accelerator Laboratory has been operated first at 2.0 GeV since 1995, and later was upgraded to 2.5 GeV. During this time, 6 insertion devices like undulators and multipole wigglers have been put into operation to produce special photon beams, with a total of 27 beamlines installed and 3 beamlines under construction. Recently, Korea synchrotron user's community is demanding high beam stability, higher photon energies as well as more straight sections for insertion devices in the PLS. To meet the user requirements, the PLS-II upgrade program has been launched in January, 2009, incorporating a modified chromatic version of Double Bend Achromat (DBA) to achieve almost twice as many straight sections as the current PLS with a design goal of the relatively low emittance, {epsilon}, of 5.9 nm{center_dot}rad. In the PLS-II, the top-up injection using full energy linac is planned for much higher stable beam as well and thus the production of hard x-ray undulator radiation of 8 to 13 keV is anticipated to allow for the successful research program namely Protein Crystallography. The PLS-II machine components of storage ring, linear accelerator and photon beamlines will be partly dismantled and reinstalled in a 6-months shutdown beginning January, 2011 and then the PLS-II upgrade be started the initial commissioning with a 100 mA beam current from July in 2011.

43 PARTICLE ACCELERATORS↗

The NEMO-3 results after completion of data taking

The double beta decay experiment NEMO-3 has compleated data taking in January 2011. The aim of the experiment is to search for the neutrinoless double beta decay and investigate the two-neutrino double beta decay in seven different isotopes ({sup 100}Mo, {sup 82}Se, {sup 116}Cd, {sup 150}Nd, {sup 96}Zr, {sup 48}Ca and {sup 130}Te). After analysis of the most part of available data corresponding to 4.5 yr no evidence for 0{nu}{beta}{beta} decay in {sup 100}Mo and {sup 82}Se is found. The half-life limits at 90% C.L. are 1.0x10{sup 24} yr and 3.2x10{sup 23} yr respectively. The two-neutrino decay half live values were precisely measured for all investigated isotopes.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Results of the double beta decay experiment NEMO-3

The double beta decay experiment NEMO-3 has taken data from February 2003 to January 2011. The two-neutrino decay half lives were measured for seven different isotopes ({sup 100}Mo, {sup 82}Se, {sup 116}Cd, {sup 150}Nd, {sup 96}Zr, {sup 48}Ca and {sup 130}Te). No evidence for neutrinoless double beta decay is observed. The 0νββ half-life limits are found to be T{sub 1/2}{sup 0ν}({sup 100}Mo)>1.0×10{sup 24}yr(90%C.L.) and T{sub 1/2}{sup 0ν}({sup 82}Se)>3.2×10{sup 23}yr(90%C.L.)

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Patient dose estimation from CT scans at the Mexican National Neurology and Neurosurgery Institute

In the radiology department of the Mexican National Institute of Neurology and Neurosurgery, a dedicated institute in Mexico City, on average 19.3 computed tomography (CT) examinations are performed daily on hospitalized patients for neurological disease diagnosis, control scans and follow-up imaging. The purpose of this work was to estimate the effective dose received by hospitalized patients who underwent a diagnostic CT scan using typical effective dose values for all CT types and to obtain the estimated effective dose distributions received by surgical and non-surgical patients. Effective patient doses were estimated from values per study type reported in the applications guide provided by the scanner manufacturer. This retrospective study included all hospitalized patients who underwent a diagnostic CT scan between 1 January 2011 and 31 December 2012. A total of 8777 CT scans were performed in this two-year period. Simple brain scan was the CT type performed the most (74.3%) followed by contrasted brain scan (6.1%) and head angiotomography (5.7%). The average number of CT scans per patient was 2.83; the average effective dose per patient was 7.9 mSv; the mean estimated radiation dose was significantly higher for surgical (9.1 mSv) than non-surgical patients (6.0 mSv). Three percent of the patients had 10 or more brain CT scans and exceeded the organ radiation dose threshold set by the International Commission on Radiological Protection for deterministic effects of the eye-lens. Although radiation patient doses from CT scans were in general relatively low, 187 patients received a high effective dose (>20 mSv) and 3% might develop cataract from cumulative doses to the eye lens.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

CN MORPHOLOGY STUDIES OF COMET 103P/HARTLEY 2

We report on narrowband CN imaging of Comet 103P/Hartley 2 obtained at Lowell Observatory on 39 nights from 2010 July until 2011 January. We observed two features, one generally to the north and the other generally to the south. The CN morphology varied during the apparition: no morphology was seen in July; in August and September, the northern feature dominated and appeared as a mostly face-on spiral; in October, November, and December, the northern and southern features were roughly equal in brightness and looked like more side-on corkscrews; in January, the southern feature was dominant but the morphology was indistinct due to very low signal. The morphology changed smoothly during each night and similar morphology was seen from night to night. However, the morphology did not exactly repeat each rotation cycle, suggesting that there is a small non-principal axis rotation. Based on the repetition of the morphology, we find evidence that the fundamental rotation period was increasing: 16.7 hr from August 13 to 17, 17.2 hr from September 10 to 13, 18.2 hr from October 12 to 19, and 18.7 hr from October 31 to November 7. We conducted Monte Carlo jet modeling to constrain the pole orientation and locations of the active regions based on the observed morphology. Our preliminary, self-consistent pole solution has an obliquity of 10{sup 0} relative to the comet's orbital plane (i.e., it is centered near R.A. = 257{sup 0} and decl. = +67{sup 0} with an uncertainty around this position of about 15{sup 0}) and has two mid-latitude sources, one in each hemisphere.

79 ASTRONOMY AND ASTROPHYSICS↗

PHOTOMETRIC PROPERTIES OF SELECTED ALGOL-TYPE BINARIES. III. AL GEMINORUM AND BM MONOCEROTIS WITH POSSIBLE LIGHT-TIME ORBITS

We present the CCD photometry of two Algol-type binaries, AL Gem and BM Mon, observed from 2008 November to 2011 January. With the updated Wilson-Devinney program, photometric solutions were deduced from their EA-type light curves. The mass ratios and fill-out factors of the primaries are found to be q{sub ph} = 0.090({+-} 0.005) and f{sub 1} = 47.3%({+-} 0.3%) for AL Gem, and q{sub ph} = 0.275({+-} 0.007) and f{sub 1} = 55.4%({+-} 0.5%) for BM Mon, respectively. By analyzing the O-C curves, we discovered that the periods of AL Gem and BM Mon change in a quasi-sinusoidal mode, which may possibly result from the light-time effect via the presence of a third body. Periods, amplitudes, and eccentricities of light-time orbits are 78.83({+-} 1.17) yr, 0fd0204({+-}0fd0007), and 0.28({+-} 0.02) for AL Gem and 97.78({+-} 2.67) yr, 0fd0175({+-}0fd0006), and 0.29({+-} 0.02) for BM Mon, respectively. Assumed to be in a coplanar orbit with the binary, the masses of the third bodies would be 0.29 M{sub Sun} for AL Gem and 0.26 M{sub Sun} for BM Mon. This kind of additional companion can extract angular momentum from the close binary orbit, and such processes may play an important role in multiple star evolution.

79 ASTRONOMY AND ASTROPHYSICS↗

A QUARTER-CENTURY OF OBSERVATIONS OF COMET 10P/TEMPEL 2 AT LOWELL OBSERVATORY: CONTINUED SPIN-DOWN, COMA MORPHOLOGY, PRODUCTION RATES, AND NUMERICAL MODELING

We report on photometry and imaging of Comet 10P/Tempel 2 obtained at Lowell Observatory from 1983 through 2011. We measured a nucleus rotation period of 8.950 {+-} 0.002 hr from 16 nights of imaging acquired between 2010 September and 2011 January. This rotation period is longer than the period we previously measured in 1999, which was itself longer than the period measured in 1988, and demonstrates that Tempel 2 is continuing to spin down, presumably due to torques caused by asymmetric outgassing. A nearly linear jet was observed which varied little during a rotation cycle in both R and CN images acquired during the 1999 and 2010 apparitions. We measured the projected direction of this jet throughout the two apparitions and, under the assumption that the source region of the jet was near the comet's pole, determined a rotational pole direction of R.A./decl. = 151 Degree-Sign /+59 Degree-Sign from CN measurements and R.A./decl. = 173 Degree-Sign /+57 Degree-Sign from dust measurements (we estimate a circular uncertainty of 3 Degree-Sign for CN and 4 Degree-Sign for dust). Different combinations of effects likely bias both gas and dust solutions and we elected to average these solutions for a final pole direction of R.A./decl. = 162 Degree-Sign {+-} 11 Degree-Sign /+58 Degree-Sign {+-} 1 Degree-Sign . Photoelectric photometry was acquired on 3 nights in 1983, 2 nights in 1988, 19 nights in 1999/2000, and 10 nights in 2010/2011. The activity exhibited a steep 'turn-on' {approx}3 months prior to perihelion (the exact timing of which varies) and a relatively smooth decline after perihelion. The activity during the 1999 and 2010 apparitions was similar; limited data in 1983 and 1988 (along with IUE data from the literature) were systematically higher and the difference cannot be explained entirely by the smaller perihelion distance. We measured a 'typical' composition, in agreement with previous investigators. Monte Carlo numerical modeling with our pole solution best replicated the observed coma morphology for a source region located near a comet latitude of +80 Degree-Sign and having a radius of {approx}10 Degree-Sign . Our model reproduced the seasonal changes in activity, suggesting that the majority of Tempel 2's activity originates from a small active region located near the pole. We also find that a cosine-squared solar angle function gives the best fit as compared to a standard cosine function.

79 ASTRONOMY AND ASTROPHYSICS↗

SIMULTANEOUS OBSERVATIONS OF SiO AND H{sub 2}O MASERS TOWARD KNOWN STELLAR H{sub 2}O MASER SOURCES

We present the results of simultaneous observations of SiO v = 1, 2, {sup 29}SiO v = 0, J = 1-0, and H{sub 2}O 6{sub 16}-5{sub 23} maser lines toward 152 known stellar H{sub 2}O maser sources using the Yonsei 21 m radio telescope of the Korean VLBI Network from 2009 June to 2011 January. Both SiO and H{sub 2}O masers were detected from 62 sources with a detection rate of 40.8%. The SiO-only maser emission without H{sub 2}O maser detection was detected from 27 sources, while the H{sub 2}O-only maser without SiO maser detection was detected from 22 sources. Therefore, the overall SiO maser emission was detected from 89 sources, resulting in a detection rate of 58.6%. We have identified 70 new detections of the SiO maser emission. For both H{sub 2}O and SiO maser detected sources, the peak and integrated antenna temperatures of SiO masers are stronger than those of H{sub 2}O masers in both Mira variables and OH/IR stars and the relative intensity ratios of H{sub 2}O to SiO masers in OH/IR stars are larger than those in Mira variables. In addition, distributions of 152 observed sources were investigated in the IRAS two-color diagram.

79 ASTRONOMY AND ASTROPHYSICS↗

REVERBERATION MAPPING RESULTS FOR FIVE SEYFERT 1 GALAXIES

We present the results from a detailed analysis of photometric and spectrophotometric data on five Seyfert 1 galaxies observed as a part of a recent reverberation mapping program. The data were collected at several observatories over a 140 day span beginning in 2010 August and ending in 2011 January. We obtained high sampling-rate light curves for Mrk 335, Mrk 1501, 3C 120, Mrk 6, and PG 2130+099, from which we have measured the time lag between variations in the 5100 A continuum and the H{beta} broad emission line. We then used these measurements to calculate the mass of the supermassive black hole at the center of each of these galaxies. Our new measurements substantially improve previous measurements of M{sub BH} and the size of the broad line-emitting region for four sources and add a measurement for one new object. Our new measurements are consistent with photoionization physics regulating the location of the broad line region in active galactic nuclei.

79 ASTRONOMY AND ASTROPHYSICS↗